Effect of epidermal growth factor in HLA class I and class II transcription and protein expression in human breast adenocarcinoma cell lines
- PMID: 1637682
- PMCID: PMC1977879
- DOI: 10.1038/bjc.1992.222
Effect of epidermal growth factor in HLA class I and class II transcription and protein expression in human breast adenocarcinoma cell lines
Abstract
The spontaneous expression of HLA class I and class II molecules in two human breast carcinoma cell lines (MCF7, T47D) and their modulation during epidermal growth factor treatment are reported. Transcription was analysed by Northern blot and hybridisation with HLA class II and class I cDNA specific probes. The expression of cell surface determinants was examined by internal protein labelling with 35s-methionine, immunoprecipitation with monoclonal antibodies specific for HLA class I or class II, followed by isolation of the immune complex on protein A-Sepharose; at least a quantification of glycoprotein was performed by chromatofocusing. Glycoprotein quantification showed a significant increase of HLA class I and class II (DR) antigen expression after stimulation by epidermal growth factor (0.02 microgram ml-1) in the two cell lines, when compared with untreated cell controls. However, with epidermal growth factor treatment of MCF7 and T47D cells, low increases in the amounts of HLA class I and class II RNA were obtained. These differences between expressed antigens and correspondent RNA amounts would be explained by the fact that EGF in these two cell lines acts more in post-transcription for HLA class I and class II antigens.
Similar articles
-
Effect of gamma interferon on HLA class-I and -II transcription and protein expression in human breast adenocarcinoma cell lines.Int J Cancer. 1990 Jun 15;45(6):1169-76. doi: 10.1002/ijc.2910450630. Int J Cancer. 1990. PMID: 2112515
-
Patterns of constitutive and IFN-gamma inducible expression of HLA class II molecules in human melanoma cell lines.Immunogenetics. 2007 Feb;59(2):123-33. doi: 10.1007/s00251-006-0171-9. Epub 2006 Dec 20. Immunogenetics. 2007. PMID: 17180681
-
Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.J Exp Med. 1995 Apr 1;181(4):1411-23. doi: 10.1084/jem.181.4.1411. J Exp Med. 1995. PMID: 7699327 Free PMC article.
-
Combined immunodeficiency with defective expression in MHC class II genes.Immunodefic Rev. 1989;1(2):135-53. Immunodefic Rev. 1989. PMID: 2517209 Review.
-
The regulation of expression of histocompatibility antigens on the cell surface; molecular genetic basis.Folia Biol (Praha). 1995;41(3-4):163-77. Folia Biol (Praha). 1995. PMID: 7589712 Review.
Cited by
-
Glioma stem cell-targeted dendritic cells as a tumor vaccine against malignant glioma.Yonsei Med J. 2013 Jan 1;54(1):92-100. doi: 10.3349/ymj.2013.54.1.92. Yonsei Med J. 2013. PMID: 23225804 Free PMC article.
-
HLA-DR and beta 2 microglobulin expression in medullary and atypical medullary carcinoma of the breast: histopathologically similar but biologically distinct entities.J Clin Pathol. 2000 Apr;53(4):286-91. doi: 10.1136/jcp.53.4.286. J Clin Pathol. 2000. PMID: 10823125 Free PMC article.
-
LncRNA USP30-AS1 promotes the survival of acute myeloid leukemia cells by cis-regulating USP30 and ANKRD13A.Hum Cell. 2022 Jan;35(1):360-378. doi: 10.1007/s13577-021-00636-7. Epub 2021 Oct 25. Hum Cell. 2022. PMID: 34694569 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials